Skip to content

Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion

Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion - The ASAP II Trial

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04792970
Enrollment
4
Registered
2021-03-11
Start date
2021-03-18
Completion date
2022-10-07
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Pleural Effusion

Brief summary

The purpose of this study is to compare the experiences of subjects who drain malignant (cancerous) pleural effusions (fluid) from around their lung(s) in a more frequent manner using a talc instilled via tunneled pleural catheter combined with daily drainage and those subjects who drain this fluid in a daily standard manner.

Detailed description

Study Activities: Patients will be randomized to either the standard daily drainage group or the talc instilled via tunneled pleural catheter combined with standard daily drainage group. Patients will complete questionnaires regarding their health. If you are randomized to the talc group, you will receive talc infused through the tunneled pleural catheter. If you are randomized to the standard daily drainage group, you will not receive any additional therapy. Patients will complete a drainage diary for everyday they drain fluid which will provide information on drainage volume, fluid color, pain, and complications. At 30 days and 90 days post randomization, patients will return to clinic for follow-up, at which time they will have a physical exam, chest x-ray, and complete questionnaires regarding their health. Risks/Safety Issues: Risks associated with talc include fever and pain. Less likely risks associated with talc include infection, dyspnea, hypoxemia, pneumonia, unilateral pulmonary edema, hemoptysis, pulmonary emboli, and bronchopleural fistula.

Interventions

DRUGTalc

All patients randomized to the Talc arm will receive Talc therapy through the pleural catheter.

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Male or female, at least 18 years of age, inclusive. 2. Subject has a symptomatic MPE requiring intervention. For an effusion to be defined as malignant, at least one of the following must be true: 1. There is histocytological confirmation of pleural malignancy 2. The effusion is an exudate (per Light's criteria) in the context of histocytologically proven malignancy elsewhere, with no other clear cause for fluid identified. 3. Subject has a history of at least 1 ipsilateral pleural effusion causing dyspnea that responded to thoracentesis where the lung expanded and the dyspnea was improved. 4. Subject is willing and able to provide written informed consent. 5. Subject is willing and able to meet all study requirements, including follow-up visits and receiving study-related telephone calls. 6. Subject has sufficient pleural fluid to allow safe insertion of an IPC. 7. Subject has negative pregnancy test if appropriate. 8. Subject or caregiver is able to perform home drainage of the pleural effusion (a caregiver can be a friend, family member, or paid healthcare professional).

Exclusion criteria

1. Subject has significant trapped lung, or a proximal bronchial obstruction which is likely to lead to trapped lung. For a subject to be eligible for this study, two separate study center clinicians must agree that there is no significant trapped lung on the same CXR using visual estimation (reference guide). The CXR used to make this decision must have been performed ≤30 days preceding the consent form being signed, and must have been performed preferably on the same day, but no more than 7 calendar days after tunneled pleural catheter insertion. Significant trapped lung is deemed present if any 1 of the following criteria is met: 1. A CXR shows hydropneumothorax other than small (\< 1 cm between chest wall and pleural line) apical pneumothoraces. 2. A CXR shows ≥20% of the affected hemithorax to be free of the expected lung parenchymal markings and there is no suggestion of pleural fluid. 3. A CXR shows ≥20% of the affected hemithorax to be occupied with pleural fluid AFTER a pleural aspiration which resulted in symptoms suggestive of trapped lung (e.g., chest pain or cough). 2. Subject has a Karnofsky score \<50, or a World Health Organization (WHO)/ Eastern Cooperative Oncology Group (ECOG) performance status ≥3. Subjects who have a performance status of 3 may be considered for the study if the removal of their fluid would likely improve their performance score by 1 or more. 3. Subject is pregnant, planning to become pregnant, or is lactating. 4. Subject has a history of empyema. 5. Subject has a history of chylothorax. 6. Subject has an uncorrected coagulopathy.

Design outcomes

Primary

MeasureTime frame
Percentage of Participants Undergoing Accelerated PleurodesisUp to 90 Days

Secondary

MeasureTime frameDescription
Dyspnea as Measured by QuestionnaireBaseline, 30 days, 90 DaysBorg Dyspnea Scale was used to rate difficulty of breathing. This scale starts at number 0 where breathing is causing no difficulty at all and progresses through to number 10 where breathing difficulty is maximal. Lower scores on this scale equal a better outcome.
Qualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselineBaselineMedical Outcomes Study Questionnaire Short Form 36 Health Survey (SF-36) was evaluated for overall health status. The SF-36 is composed of eight multi-item scales (Physical functioning, Role limitations due to physical health, Role limitations due to emotional problems, Energy/fatigue, Emotional well-being, Social functioning, Pain, General health), with scores for each of these scales (or dimensions) ranging from 0 to 100. Higher scores indicate higher qualify of life.
Qualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 Days30 daysMedical Outcomes Study Questionnaire Short Form 36 Health Survey (SF-36) was evaluated for overall health status. The SF-36 is composed of eight multi-item scales (Physical functioning, Role limitations due to physical health, Role limitations due to emotional problems, Energy/fatigue, Emotional well-being, Social functioning, Pain, General health), with scores for each of these scales (or dimensions) ranging from 0 to 100. Higher scores indicate higher qualify of life.
Qualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 90 Days90 daysMedical Outcomes Study Questionnaire Short Form 36 Health Survey (SF-36) was evaluated for overall health status. The SF-36 is composed of eight multi-item scales (Physical functioning, Role limitations due to physical health, Role limitations due to emotional problems, Energy/fatigue, Emotional well-being, Social functioning, Pain, General health), with scores for each of these scales (or dimensions) ranging from 0 to 100. Higher scores indicate higher qualify of life.

Countries

United States

Participant flow

Participants by arm

ArmCount
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily Drainage
This arm consists of eligible participants who are randomized to the Talc arm and would receive Talc therapy instilled into the pleural catheter. Talc: All patients randomized to the Talc arm will receive Talc therapy through the pleural catheter.
2
Standard Daily Drainage
This arm consists of eligible participants who are randomized to control group and would not receive any intervention.
2
Total4

Baseline characteristics

CharacteristicTalc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageStandard Daily DrainageTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants1 Participants1 Participants
Age, Categorical
Between 18 and 65 years
2 Participants1 Participants3 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
2 Participants2 Participants4 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
1 Participants0 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
1 Participants2 Participants3 Participants
Region of Enrollment
United States
2 Participants2 Participants4 Participants
Sex: Female, Male
Female
2 Participants2 Participants4 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 20 / 2
other
Total, other adverse events
0 / 22 / 2
serious
Total, serious adverse events
1 / 21 / 2

Outcome results

Primary

Percentage of Participants Undergoing Accelerated Pleurodesis

Time frame: Up to 90 Days

Population: Only participants who underwent pleurodesis while on study are included in the analysis

ArmMeasureValue (NUMBER)
Standard Daily DrainagePercentage of Participants Undergoing Accelerated Pleurodesis100 percentage of participants
Secondary

Dyspnea as Measured by Questionnaire

Borg Dyspnea Scale was used to rate difficulty of breathing. This scale starts at number 0 where breathing is causing no difficulty at all and progresses through to number 10 where breathing difficulty is maximal. Lower scores on this scale equal a better outcome.

Time frame: Baseline, 30 days, 90 Days

Population: Data not collected on Standard Daily Drainage participant at day 90 due to pleurodesis at the day 30 follow-up visit.

ArmMeasureGroupValue (NUMBER)
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageDyspnea as Measured by QuestionnaireBaseline2 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageDyspnea as Measured by QuestionnaireDay 302 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageDyspnea as Measured by QuestionnaireDay 900 score on a scale
Standard Daily DrainageDyspnea as Measured by QuestionnaireBaseline0.5 score on a scale
Standard Daily DrainageDyspnea as Measured by QuestionnaireDay 301 score on a scale
Secondary

Qualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 Days

Medical Outcomes Study Questionnaire Short Form 36 Health Survey (SF-36) was evaluated for overall health status. The SF-36 is composed of eight multi-item scales (Physical functioning, Role limitations due to physical health, Role limitations due to emotional problems, Energy/fatigue, Emotional well-being, Social functioning, Pain, General health), with scores for each of these scales (or dimensions) ranging from 0 to 100. Higher scores indicate higher qualify of life.

Time frame: 30 days

ArmMeasureGroupValue (NUMBER)
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysPhysical functioning25 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysRole limitations due to physical health25 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysRole limitations due to emotional problems33.3 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysEnergy/fatigue45 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysEmotional well-being60 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysSocial functioning62.5 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysPain90 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysGeneral health35 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysGeneral health35 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysPhysical functioning5 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysEmotional well-being60 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysRole limitations due to physical health0 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysPain32.5 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysRole limitations due to emotional problems0 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysSocial functioning25 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 30 DaysEnergy/fatigue40 score on a scale
Secondary

Qualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 90 Days

Medical Outcomes Study Questionnaire Short Form 36 Health Survey (SF-36) was evaluated for overall health status. The SF-36 is composed of eight multi-item scales (Physical functioning, Role limitations due to physical health, Role limitations due to emotional problems, Energy/fatigue, Emotional well-being, Social functioning, Pain, General health), with scores for each of these scales (or dimensions) ranging from 0 to 100. Higher scores indicate higher qualify of life.

Time frame: 90 days

Population: Data not collected on Standard Daily Drainage participant at day 90 due to pleurodesis at the day 30 follow-up visit.

ArmMeasureGroupValue (NUMBER)
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 90 DaysSocial functioning50 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 90 DaysEnergy/fatigue0 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 90 DaysPhysical functioning5 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 90 DaysRole limitations due to physical health0 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 90 DaysRole limitations due to emotional problems33.3 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 90 DaysEmotional well-being84 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 90 DaysPain62.5 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at 90 DaysGeneral health35 score on a scale
Secondary

Qualify of Life as Measured by Short Form 36 Health Survey (SF-36) at Baseline

Medical Outcomes Study Questionnaire Short Form 36 Health Survey (SF-36) was evaluated for overall health status. The SF-36 is composed of eight multi-item scales (Physical functioning, Role limitations due to physical health, Role limitations due to emotional problems, Energy/fatigue, Emotional well-being, Social functioning, Pain, General health), with scores for each of these scales (or dimensions) ranging from 0 to 100. Higher scores indicate higher qualify of life.

Time frame: Baseline

ArmMeasureGroupValue (NUMBER)
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselinePhysical functioning30 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselineEmotional well-being56 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselineRole limitations due to emotional problems33.3 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselineSocial functioning50 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselineRole limitations due to physical health0 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselinePain62.5 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselineGeneral health30 score on a scale
Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselineEnergy/fatigue50 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselineGeneral health20 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselinePhysical functioning25 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselineRole limitations due to physical health0 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselineRole limitations due to emotional problems0 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselineEnergy/fatigue25 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselineEmotional well-being72 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselineSocial functioning25 score on a scale
Standard Daily DrainageQualify of Life as Measured by Short Form 36 Health Survey (SF-36) at BaselinePain0 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026